Background
There has been increasing evidence that physicians in gynaecology are not routinely enquiring about work during consultations.
Aims
To explore the effect gynaecological conditions can have on work functioning, the importance of work outcomes among patients and whether work considerations are discussed during clinical consultations.
Methods
A cross-sectional survey was administered to employed patients attending a gynaecological clinic at Guy’s Hospital. The survey assessed four areas: demographics, gynaecological condition (including self-assessed severity), work status and perceived impact of the condition on work functioning and job satisfaction. Simple descriptive analysis and statistical techniques were used to interpret the data.
Results
One hundred and six participants participated (mean age: 37.49 ± 9.09). About 95% found it important to be able to work whilst receiving treatment and 82% of patients had reported at least a slight impact on their working ability due to their condition. Of the 31 patients for whom it was their first appointment, 77% said it would be useful to discuss the possible impacts their gynaecological condition could have on their work. About 66% (19/29) of the participants attending a follow-up appointment reported that their doctor had not discussed their work with them.
Conclusions
The symptoms of gynaecological conditions can impact patients’ ability to work. There is a lack of useful discussion from doctors about the perceived impact gynaecological conditions can have on a patient’s ability to work, despite patients finding it important to be able to remain or return to work.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.